Breakthroughs

https://simplecast.com Breakthroughs Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Produced and funded by Pfizer Ltd. PP-UNP-GBR-13569 / October 2025 2022-2025 Pfizer en Mon, 15 Dec 2025 09:00:00 +0000 Mon, 15 Dec 2025 09:00:12 +0000 https://breakthroughs.simplecast.com Breakthroughs https://image.simplecastcdn.com/images/4ba7d5eb-ce04-4829-abd5-ef44bb34e678/6f992d14-3fbe-4f44-a316-f817af70d9ce/3000x3000/podcast-cover-artwork-final-3000x3000px-2025.jpg?aid=rss_feed https://breakthroughs.simplecast.com episodic Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Produced and funded by Pfizer Ltd. PP-UNP-GBR-13569 / October 2025 Pfizer false

https://feeds.simplecast.com/Lsj7gegY

covid, covid-19, health policy, healthcare, life sciences, medicine development, pfizer, pfizer uk, pharmaceuticals, amr, antimicrobial resistance, science, rare disease, pfizer uk podcast, pfizer podcast, life sciences podcast, pharma podcast, covid-19 pfizer, breakthroughs, pfizer breakthroughs, breakthroughs with pfizer, pfizer uk breakthroughs, breakthroughs with pfizer uk, cancer, antibiotic resistance, health, ellie cannon, migraine, oncology, health inequalities, immunisation, sickle cell Pfizer pfizerpodcasts@pfizer.com 99e0903f-7f59-4363-9cf3-55a3c191a874 Part of the Story: Sherlock Holmes and The Adventure of the Silent Hiss Despite recent scientific progress, society and particularly the media oversimplifies, or sensationalises cancer. The way that cancer is portrayed does not reflect the reality for patients today.

We’ve created a new chapter, ‘The Adventure of the Silent Hiss’, to ‘The Return of Sherlock Holmes’ collection of short stories, which sees the famous detective navigate a cancer diagnosis while successfully solving another mystery.

Written in collaboration with patients and narrated by voice actor and cancer survivor, Brett Harman, the new chapter aims to shift the narrative to better reflect the fact that advances in treatment and detection are helping many people with the disease live better and longer lives.

Whether cancer comes at the beginning, middle or end of a person’s life, it is never the whole story and does not need to define it.

This story, inspired by characters created by Sir Arthur Conan Doyle, was commissioned and funded by Pfizer Ltd. It takes artistic licence but is informed by insights from people living with cancer. It is intended for the UK general public and is not meant to replace the advice of a qualified health professional.

PP-UNP-GBR-13946 / December 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Mon, 15 Dec 2025 09:00:00 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/part-of-the-story-sherlock-holmes-and-the-adventure-of-the-silent-hiss-2abDzzz7 Despite recent scientific progress, society and particularly the media oversimplifies, or sensationalises cancer. The way that cancer is portrayed does not reflect the reality for patients today.

We’ve created a new chapter, ‘The Adventure of the Silent Hiss’, to ‘The Return of Sherlock Holmes’ collection of short stories, which sees the famous detective navigate a cancer diagnosis while successfully solving another mystery.

Written in collaboration with patients and narrated by voice actor and cancer survivor, Brett Harman, the new chapter aims to shift the narrative to better reflect the fact that advances in treatment and detection are helping many people with the disease live better and longer lives.

Whether cancer comes at the beginning, middle or end of a person’s life, it is never the whole story and does not need to define it.

This story, inspired by characters created by Sir Arthur Conan Doyle, was commissioned and funded by Pfizer Ltd. It takes artistic licence but is informed by insights from people living with cancer. It is intended for the UK general public and is not meant to replace the advice of a qualified health professional.

PP-UNP-GBR-13946 / December 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Part of the Story: Sherlock Holmes and The Adventure of the Silent Hiss Pfizer 00:25:26 Despite recent scientific progress, society and particularly the media oversimplifies, or sensationalises cancer. The way that cancer is portrayed does not reflect the reality for patients today. We’ve created a new chapter, ‘The Adventure of the Silent Hiss’, to ‘The Return of Sherlock Holmes’ collection of short stories, which sees the famous detective navigate a cancer diagnosis while successfully solving another mystery. Written in collaboration with patients and narrated by voice actor and cancer survivor, Brett Harman, the new chapter aims to shift the narrative to better reflect the fact that advances in treatment and detection are helping many people with the disease live better and longer lives. Whether cancer comes at the beginning, middle or end of a person’s life, it is never the whole story and does not need to define it. This story, inspired by characters created by Sir Arthur Conan Doyle, was commissioned and funded by Pfizer Ltd. It takes artistic licence but is informed by insights from people living with cancer. It is intended for the UK general public and is not meant to replace the advice of a qualified health professional. PP-UNP-GBR-13946 / December 2025 Despite recent scientific progress, society and particularly the media oversimplifies, or sensationalises cancer. The way that cancer is portrayed does not reflect the reality for patients today. We’ve created a new chapter, ‘The Adventure of the Silent Hiss’, to ‘The Return of Sherlock Holmes’ collection of short stories, which sees the famous detective navigate a cancer diagnosis while successfully solving another mystery. Written in collaboration with patients and narrated by voice actor and cancer survivor, Brett Harman, the new chapter aims to shift the narrative to better reflect the fact that advances in treatment and detection are helping many people with the disease live better and longer lives. Whether cancer comes at the beginning, middle or end of a person’s life, it is never the whole story and does not need to define it. This story, inspired by characters created by Sir Arthur Conan Doyle, was commissioned and funded by Pfizer Ltd. It takes artistic licence but is informed by insights from people living with cancer. It is intended for the UK general public and is not meant to replace the advice of a qualified health professional. PP-UNP-GBR-13946 / December 2025 part of the story, science, pfizer breakthroughs, adventures of the silent hiss, sherlock holmes, pfizer uk, pfizer, brett harman, oncology, silent hiss, sherlock, breakthroughs with pfizer uk, health, healthcare, breakthroughs, career, pharma false full 14 5cc9ca00-c59c-45cc-aee3-48187b60611e Confronting the stigma of lung cancer To end season 2, our expert panel discusses some of the challenges and misconceptions that need to be overcome in the fight against lung cancer and the progress being made. Our host Dr Ellie Cannon is joined by Dr Jesme Fox, Medical Director at the Roy Castle Lung Cancer Foundation, and Stefano Podesta, Oncology Commercial Lead at Pfizer UK.

PP-UNP-GBR-13858 / December 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 10 Dec 2025 07:00:00 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/confronting-the-stigma-of-lung-cancer-A36PrgPj To end season 2, our expert panel discusses some of the challenges and misconceptions that need to be overcome in the fight against lung cancer and the progress being made. Our host Dr Ellie Cannon is joined by Dr Jesme Fox, Medical Director at the Roy Castle Lung Cancer Foundation, and Stefano Podesta, Oncology Commercial Lead at Pfizer UK.

PP-UNP-GBR-13858 / December 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Confronting the stigma of lung cancer Pfizer 00:27:12 To end season 2, our expert panel discusses some of the challenges and misconceptions that need to be overcome in the fight against lung cancer and the progress being made. Our host Dr Ellie Cannon is joined by Dr Jesme Fox, Medical Director at the Roy Castle Lung Cancer Foundation, and Stefano Podesta, Oncology Commercial Lead at Pfizer UK. PP-UNP-GBR-13858 / December 2025 To end season 2, our expert panel discusses some of the challenges and misconceptions that need to be overcome in the fight against lung cancer and the progress being made. Our host Dr Ellie Cannon is joined by Dr Jesme Fox, Medical Director at the Roy Castle Lung Cancer Foundation, and Stefano Podesta, Oncology Commercial Lead at Pfizer UK. PP-UNP-GBR-13858 / December 2025 science, pfizer breakthroughs, pfizer uk, pfizer, ellie cannon, roy castle, roy castle lung cancer, lung cancer, cancer, breakthroughs with pfizer uk, health, healthcare, breakthroughs, pharma false full 13 eb903ca3-ca99-4f31-8ee0-8e4626a7fe94 Breast cancer: widely known, but often overlooked Our expert panel discusses the progress being made in the fight against breast cancer and some of the challenges that need to be tackled to improve patient care in the future. Our host Dr Ellie Cannon is joined by Helen Dickens, Chief Support Officer at Breast Cancer Now, and Colm Doody, Oncology Medical Director at Pfizer UK.

PP-UNP-GBR-13734 / November 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 3 Dec 2025 07:00:00 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/breast-cancer-widely-known-but-often-overlooked-_uhfIURJ Our expert panel discusses the progress being made in the fight against breast cancer and some of the challenges that need to be tackled to improve patient care in the future. Our host Dr Ellie Cannon is joined by Helen Dickens, Chief Support Officer at Breast Cancer Now, and Colm Doody, Oncology Medical Director at Pfizer UK.

PP-UNP-GBR-13734 / November 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Breast cancer: widely known, but often overlooked Pfizer 00:37:02 Our expert panel discusses the progress being made in the fight against breast cancer and some of the challenges that need to be tackled to improve patient care in the future. Our host Dr Ellie Cannon is joined by Helen Dickens, Chief Support Officer at Breast Cancer Now, and Colm Doody, Oncology Medical Director at Pfizer UK. PP-UNP-GBR-13734 / November 2025 Our expert panel discusses the progress being made in the fight against breast cancer and some of the challenges that need to be tackled to improve patient care in the future. Our host Dr Ellie Cannon is joined by Helen Dickens, Chief Support Officer at Breast Cancer Now, and Colm Doody, Oncology Medical Director at Pfizer UK. PP-UNP-GBR-13734 / November 2025 science, pfizer breakthroughs, pfizer uk, pfizer, breast cancer, ellie cannon, breakthroughs with pfizer, breast cancer now, cancer, health, healthcare, breakthroughs, pharma false full 12 6664ee12-3ac7-4d84-bd8a-84eac2178617 A fair shot: exploring vaccines access and equity Dr Ellie Cannon is joined by Lord Bethell, Member of the House of Lords, and Hetal Naik, Primary Care Lead at Pfizer UK, to discuss the evolving role of vaccines in the UK’s prevention strategy and how to help improve equitable vaccine access.

PP-UNP-GBR-13788 / November 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Thu, 20 Nov 2025 15:35:19 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/a-fair-shot-exploring-vaccines-access-and-equity-7XnzqShp Dr Ellie Cannon is joined by Lord Bethell, Member of the House of Lords, and Hetal Naik, Primary Care Lead at Pfizer UK, to discuss the evolving role of vaccines in the UK’s prevention strategy and how to help improve equitable vaccine access.

PP-UNP-GBR-13788 / November 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> A fair shot: exploring vaccines access and equity Pfizer 00:26:32 Dr Ellie Cannon is joined by Lord Bethell, Member of the House of Lords, and Hetal Naik, Primary Care Lead at Pfizer UK, to discuss the evolving role of vaccines in the UK’s prevention strategy and how to help improve equitable vaccine access. PP-UNP-GBR-13788 / November 2025 Dr Ellie Cannon is joined by Lord Bethell, Member of the House of Lords, and Hetal Naik, Primary Care Lead at Pfizer UK, to discuss the evolving role of vaccines in the UK’s prevention strategy and how to help improve equitable vaccine access. PP-UNP-GBR-13788 / November 2025 science, prevention, pfizer breakthroughs, immunisation, pfizer uk, pfizer, ellie cannon, vaccination, vaccines, breakthroughs with pfizer, lord bethell, equitable vaccine access, health, healthcare, breakthroughs, pharma false full 11 b9ab43dd-53fb-4191-83f5-73f3f7a2247b Uncovering heart failure In this episode our expert panel discuss the topic of heart failure, exploring what it is, symptoms to be aware of, diagnosis, and the impact it can have on daily life. Our host Dr Ellie Cannon is joined by Anna Tomlinson, CEO at Cardiomyopathy UK, and Seema Patel, Specialty Care Medical Director at Pfizer UK.

PP-UNP-GBR-13584 / October 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 5 Nov 2025 17:05:14 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/uncovering-heart-failure-H7XVfIY1 In this episode our expert panel discuss the topic of heart failure, exploring what it is, symptoms to be aware of, diagnosis, and the impact it can have on daily life. Our host Dr Ellie Cannon is joined by Anna Tomlinson, CEO at Cardiomyopathy UK, and Seema Patel, Specialty Care Medical Director at Pfizer UK.

PP-UNP-GBR-13584 / October 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Uncovering heart failure Pfizer 00:34:56 In this episode our expert panel discuss the topic of heart failure, exploring what it is, symptoms to be aware of, diagnosis, and the impact it can have on daily life. Our host Dr Ellie Cannon is joined by Anna Tomlinson, CEO at Cardiomyopathy UK, and Seema Patel, Specialty Care Medical Director at Pfizer UK. PP-UNP-GBR-13584 / October 2025 In this episode our expert panel discuss the topic of heart failure, exploring what it is, symptoms to be aware of, diagnosis, and the impact it can have on daily life. Our host Dr Ellie Cannon is joined by Anna Tomlinson, CEO at Cardiomyopathy UK, and Seema Patel, Specialty Care Medical Director at Pfizer UK. PP-UNP-GBR-13584 / October 2025 heart disease, science, pfizer breakthroughs, pfizer uk, pfizer, ellie cannon, breakthroughs with pfizer, cardiomyopathy, heart failure, health, healthcare, breakthroughs, pharma false full 10 8589f95d-c7ad-4014-b39f-eee497c0a7f4 The hidden challenges of multiple myeloma In this episode our expert panel discuss multiple myeloma, exploring some of the challenges of the disease and progress being made to help patients in the UK. Our host Dr Ellie Cannon is joined by Dr Sophie Castell, CEO at Myeloma UK, and Colm Doody, Oncology Medical Director at Pfizer UK.

PP-UNP-GBR-13445 / October 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 22 Oct 2025 06:30:00 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/the-hidden-challenges-of-multiple-myeloma-cmyrhuHC In this episode our expert panel discuss multiple myeloma, exploring some of the challenges of the disease and progress being made to help patients in the UK. Our host Dr Ellie Cannon is joined by Dr Sophie Castell, CEO at Myeloma UK, and Colm Doody, Oncology Medical Director at Pfizer UK.

PP-UNP-GBR-13445 / October 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> The hidden challenges of multiple myeloma Pfizer 00:31:02 In this episode our expert panel discuss multiple myeloma, exploring some of the challenges of the disease and progress being made to help patients in the UK. Our host Dr Ellie Cannon is joined by Dr Sophie Castell, CEO at Myeloma UK, and Colm Doody, Oncology Medical Director at Pfizer UK. PP-UNP-GBR-13445 / October 2025 In this episode our expert panel discuss multiple myeloma, exploring some of the challenges of the disease and progress being made to help patients in the UK. Our host Dr Ellie Cannon is joined by Dr Sophie Castell, CEO at Myeloma UK, and Colm Doody, Oncology Medical Director at Pfizer UK. PP-UNP-GBR-13445 / October 2025 science, pfizer breakthroughs, pfizer uk, pfizer, multiple myeloma, ellie cannon, breakthroughs with pfizer, myeloma uk, health, healthcare, breakthroughs, myeloma, pharma false full 9 07ac02ae-1518-4bfe-ab44-09c5059a00c0 Gaining independence with haemophilia To kick off season 2, our panel explores the impact that haemophilia has on patients and their families and the scientific progress being made to enable people with haemophilia to lead more independent lives. Our host Dr Ellie Cannon is joined by Kate Burt, Chief Executive at The Haemophilia Society, and Seema Patel, Specialty Care Medical Director at Pfizer UK.

PP-UNP-GBR-13338 / September 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 8 Oct 2025 15:21:07 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/gaining-independence-with-haemophilia-gyJahegS To kick off season 2, our panel explores the impact that haemophilia has on patients and their families and the scientific progress being made to enable people with haemophilia to lead more independent lives. Our host Dr Ellie Cannon is joined by Kate Burt, Chief Executive at The Haemophilia Society, and Seema Patel, Specialty Care Medical Director at Pfizer UK.

PP-UNP-GBR-13338 / September 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Gaining independence with haemophilia Pfizer 00:35:17 To kick off season 2, our panel explores the impact that haemophilia has on patients and their families and the scientific progress being made to enable people with haemophilia to lead more independent lives. Our host Dr Ellie Cannon is joined by Kate Burt, Chief Executive at The Haemophilia Society, and Seema Patel, Specialty Care Medical Director at Pfizer UK. PP-UNP-GBR-13338 / September 2025 To kick off season 2, our panel explores the impact that haemophilia has on patients and their families and the scientific progress being made to enable people with haemophilia to lead more independent lives. Our host Dr Ellie Cannon is joined by Kate Burt, Chief Executive at The Haemophilia Society, and Seema Patel, Specialty Care Medical Director at Pfizer UK. PP-UNP-GBR-13338 / September 2025 science, pfizer breakthroughs, haemophilia, pfizer uk, pfizer, ellie cannon, hemophilia, breakthroughs with pfizer, health, healthcare, breakthroughs, haemophilia society, pharma false full 8 fdf6953e-aada-4598-bb3b-3d2b9bc3e5d0 The vital role of immunisation for disease prevention Dr Ellie Cannon is joined by Sir Jonathan Van-Tam OBE, Former Deputy Chief Medical Officer for England, and Dr Gillian Ellsbury, Primary Care Medical Director at Pfizer UK to discuss the role of vaccination to help prevent infectious diseases and how this can potentially reduce pressures on the NHS.

PP-UNP-GBR-10718 / November 2024

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Tue, 19 Nov 2024 09:34:02 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/the-vital-role-of-immunisation-for-disease-prevention-UtBXoOvh Dr Ellie Cannon is joined by Sir Jonathan Van-Tam OBE, Former Deputy Chief Medical Officer for England, and Dr Gillian Ellsbury, Primary Care Medical Director at Pfizer UK to discuss the role of vaccination to help prevent infectious diseases and how this can potentially reduce pressures on the NHS.

PP-UNP-GBR-10718 / November 2024

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> The vital role of immunisation for disease prevention Pfizer 00:33:46 Dr Ellie Cannon is joined by Sir Jonathan Van-Tam OBE, Former Deputy Chief Medical Officer for England, and Dr Gillian Ellsbury, Primary Care Medical Director at Pfizer UK to discuss the role of vaccination to help prevent infectious diseases and how this can potentially reduce pressures on the NHS. PP-UNP-GBR-10718 / November 2024 Dr Ellie Cannon is joined by Sir Jonathan Van-Tam OBE, Former Deputy Chief Medical Officer for England, and Dr Gillian Ellsbury, Primary Care Medical Director at Pfizer UK to discuss the role of vaccination to help prevent infectious diseases and how this can potentially reduce pressures on the NHS. PP-UNP-GBR-10718 / November 2024 pfizer breakthroughs, immunisation, covid-19, pfizer uk, pfizer, disease prevention, ellie cannon, covid, vaccination, vaccines, breakthroughs with pfizer, jvt, infectious diseases, covid19, breakthroughs with pfizer uk, health, jonathan van-tam, healthcare, breakthroughs, pharma false full 7 26c6ed8c-bc17-4412-9ac9-c645b293999e What sickle cell disease tells us about health inequalities Dr Ellie Cannon is joined by John James OBE, Chief Executive of the Sickle Cell Society and Seema Patel, Specialty Care Medical Director at Pfizer UK, to discuss health inequalities and explore what we can learn from the sickle cell community.

PP-UNP-GBR-9699 / August 2024

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Fri, 23 Aug 2024 11:01:26 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/what-sickle-cell-disease-tells-us-about-health-inequalities-p3YhGxgu Dr Ellie Cannon is joined by John James OBE, Chief Executive of the Sickle Cell Society and Seema Patel, Specialty Care Medical Director at Pfizer UK, to discuss health inequalities and explore what we can learn from the sickle cell community.

PP-UNP-GBR-9699 / August 2024

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> What sickle cell disease tells us about health inequalities Pfizer 00:34:15 Dr Ellie Cannon is joined by John James OBE, Chief Executive of the Sickle Cell Society and Seema Patel, Specialty Care Medical Director at Pfizer UK, to discuss health inequalities and explore what we can learn from the sickle cell community. PP-UNP-GBR-9699 / August 2024 Dr Ellie Cannon is joined by John James OBE, Chief Executive of the Sickle Cell Society and Seema Patel, Specialty Care Medical Director at Pfizer UK, to discuss health inequalities and explore what we can learn from the sickle cell community. PP-UNP-GBR-9699 / August 2024 pfizer breakthroughs, sickle cell, pfizer uk, pfizer, ellie cannon, health inequality, breakthroughs with pfizer, health equity, health, healthcare, health inequalities, breakthroughs, pharma false full 6 a908b7c3-4355-413d-8cd5-da739b3a15fc Understanding the impact of migraine Dr Ellie Cannon is joined by Rob Music, CEO of The Migraine Trust and Gillian Ellsbury, Primary Care Medical Director at Pfizer UK (at time of recording), to explore the impact that migraine has on individuals and wider society.

PP-UNP-GBR-13721 / November 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Fri, 12 Apr 2024 13:18:59 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/understanding-the-impact-of-migraine-hQ_JtlVk Dr Ellie Cannon is joined by Rob Music, CEO of The Migraine Trust and Gillian Ellsbury, Primary Care Medical Director at Pfizer UK (at time of recording), to explore the impact that migraine has on individuals and wider society.

PP-UNP-GBR-13721 / November 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Understanding the impact of migraine Pfizer 00:34:54 Dr Ellie Cannon is joined by Rob Music, CEO of The Migraine Trust and Gillian Ellsbury, Primary Care Medical Director at Pfizer UK (at time of recording), to explore the impact that migraine has on individuals and wider society. PP-UNP-GBR-13721 / November 2025 Dr Ellie Cannon is joined by Rob Music, CEO of The Migraine Trust and Gillian Ellsbury, Primary Care Medical Director at Pfizer UK (at time of recording), to explore the impact that migraine has on individuals and wider society. PP-UNP-GBR-13721 / November 2025 breakthrough, headache, the migraine trust, pfizer uk, migraines, pfizer, ellie cannon, understanding the impact of migraine, dr ellie cannon, impact of migraine, migraine, breakthroughs with pfizer uk, migraine trust, health, healthcare, breakthroughs false full 5 5dccafb1-03bd-4452-8e9e-7eb983fd9861 Innovation in cancer: Defining the future of care Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK.

PP-UNP-GBR-13462 / October 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 22 Nov 2023 15:00:00 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/innovation-in-cancer-defining-the-future-of-care-vCTQY48V Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK.

PP-UNP-GBR-13462 / October 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Innovation in cancer: Defining the future of care Pfizer 00:42:58 Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK. PP-UNP-GBR-13462 / October 2025 Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK. PP-UNP-GBR-13462 / October 2025 stefano podesta, science, cancer care, tackling cancer, healthacre challenges, pfizer uk, fighting cancer, pfizer, jane lyons, dr ellie cannon, oncology, innovation in cancer, rare cancer, cancer, life sciences, cancer52, healthcare, rarer cancers, breakthroughs false full 4 5bcf2643-6a6e-47ce-a4a6-eb9044c37d1f Delivering a step forward for rare disease patients Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.

PP-UNP-GBR-12704 / July 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 13 Sep 2023 14:11:54 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/delivering-a-step-forward-for-rare-disease-patients-_73dXyt1 Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.

PP-UNP-GBR-12704 / July 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Delivering a step forward for rare disease patients Pfizer 00:30:39 Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements. PP-UNP-GBR-12704 / July 2025 Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements. PP-UNP-GBR-12704 / July 2025 science, healthcare system, owen marks, rare disease, healthcare challenges, dr jacqueline barry, pfizer uk, catapult, medicines, pfizer, gene therapy, dr ellie cannon, scientific advancements, rare diseases, life sciences, healthcare, breakthroughs false full 3 eeb2041e-2cd7-4425-a94b-0f80641587ad Meeting the challenge of Antimicrobial Resistance (AMR) Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.

PP-UNP-GBR-11741 / March 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Wed, 10 May 2023 11:00:00 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/meeting-the-challenge-of-antimicrobial-resistance-Ab21RjuF Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.

PP-UNP-GBR-11741 / March 2025

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Meeting the challenge of Antimicrobial Resistance (AMR) Pfizer 00:36:13 Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society. PP-UNP-GBR-11741 / March 2025 Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society. PP-UNP-GBR-11741 / March 2025 antibiotic resistance, science, drug-resistant infections, antimicrobial resistance, amr report, infections, healthcare challenges, superbugs, pfizer uk, amr, pfizer, antibiotic overuse, dr ellie cannon, lord jim o’neill, antibiotics, healthcare, breakthroughs false full 2 016ec362-224b-408f-b399-6631e27d7f93 What can we learn from COVID-19 to address other healthcare challenges? Join Dr Ellie Cannon as she talks to Susan Rienow, Country President at Pfizer UK (at time of recording) and Dr Richard Torbett, CEO of the Association of the British Pharmaceutical Industry, about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges.

PP-UNP-GBR-10858 / November 2024

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> Sat, 10 Dec 2022 16:42:17 +0000 pfizerpodcasts@pfizer.com (Pfizer) https://breakthroughs.simplecast.com/episodes/what-can-we-learn-from-covid-19-to-address-other-healthcare-challenges-LeGMEyX4 Join Dr Ellie Cannon as she talks to Susan Rienow, Country President at Pfizer UK (at time of recording) and Dr Richard Torbett, CEO of the Association of the British Pharmaceutical Industry, about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges.

PP-UNP-GBR-10858 / November 2024

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

]]> What can we learn from COVID-19 to address other healthcare challenges? Pfizer 00:32:20 Join Dr Ellie Cannon as she talks to Susan Rienow, Country President at Pfizer UK (at time of recording) and Dr Richard Torbett, CEO of the Association of the British Pharmaceutical Industry, about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges. PP-UNP-GBR-10858 / November 2024 Join Dr Ellie Cannon as she talks to Susan Rienow, Country President at Pfizer UK (at time of recording) and Dr Richard Torbett, CEO of the Association of the British Pharmaceutical Industry, about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges. PP-UNP-GBR-10858 / November 2024 pandemic, medicine development, healthcare challenges, abpi, covid-19, pfizer uk, pfizer, covid, dr ellie cannon, pharmaceuticals, breakthroughs with pfizer, richard torbett, covid19, life sciences, healthcare, breakthroughs false full 1